With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?

With a New Diabetes Product Coming to Market, What Lies Ahead for Zealand Pharma Investors?

A new, easier-to-administer treatment for severe hypoglycemia has observers and investors wondering where its creators will go next.